Furthermore, utilizing the 5TGM1 murine MM model, they demonstrated the potential for VSVΔ51-NIS in an in vivo system, where combination treatment with 131I radiotherapy led to reduction of tumour burden and improved survival110. Here, SLC5A5 is linked to Miyoshi myopathy.